Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Precision Telemed vs HelloWellness

Two GLP-1 deals, scored on the same six factors. Precision Telemed lands a Value Score of 89, HelloWellness a 66. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Precision Telemed

#10 · Grade A · Great Deal

Est. first month

$149/mo

Save ~89% vs brand-name
Get this deal Full Precision Telemed review →
VS

HelloWellness

#304 · Grade C · Watch List

Est. first month

From $133/mo (starting dose, compounded)

Save ~90% vs brand-name
Get this deal Full HelloWellness review →

The verdict

Better value: Precision Telemed

Precision Telemed takes it on Value Score, 89 to 66 an est. $149/mo first month, with no teaser step-up baked in. HelloWellness isn't out of it: Shoppers who want price-sensitive patients ready to commit to a 3-month minimum plan.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealPrecision TelemedHelloWellness
Value Score89 (A)66 (C)
Est. first month$149/moFrom $133/mo (starting dose, compounded)
Save vs brand-name~89%~90%
Semaglutide$149/moFrom $133/mo (starting dose, compounded)
Tirzepatide$199/moFrom $166/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

88
Lowest Real Price
85
Precision Telemed: 88. HelloWellness: 85.
86
No Teaser-Rate Bait
54
Precision Telemed: 86. HelloWellness: 54.
98
Nationwide Availability
45
Precision Telemed: 98. HelloWellness: 45.
92
Both Molecules
92
Precision Telemed: 92. HelloWellness: 92.
84
Easy Cancellation
25
Precision Telemed: 84. HelloWellness: 25.
82
Reputation
68
Precision Telemed: 82. HelloWellness: 68.

Precision Telemed

A LegitScript-certified, all-50-state program with an honest $149 / $199 flat price on both molecules.

Why it's a deal

  • LegitScript-certified and available in all 50 states
  • Flat $149 semaglutide / $199 tirzepatide — no step-up
  • Both molecules priced up front

The fine print

  • Not the rock-bottom sticker — sub-$100 sema tiers exist
  • No brand-name or oral option

HelloWellness

HelloWellness (hellowellness.health) is a compounded GLP-1 telehealth platform offering compounded semaglutide starting at $133/month and compounded tirzepatide starting at $166/month, with a 3-month plan…

Why it's a deal

  • $133/mo starting price for compounded semaglutide is among the cheapest in the US compounded market
  • $166/mo starting price for compounded tirzepatide is competitive with established platforms
  • Every shipment includes syringes, needles, and injection instructions
  • Cancel anytime after the 3-month minimum, stated clearly
  • Private Facebook community for patient support

The fine print

  • 3-month minimum plan — you pay for all 3 months even if you stop early
  • LegitScript seal is for a related domain (hellowellness.ai), not hellowellness.health — confirm it's the same entity
  • Parent company / legal entity not disclosed
  • States served not listed publicly
  • Pharmacy partners not named
Get the Precision Telemed deal Get the HelloWellness deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Precision Telemed is ranked on the Precision Telemed alternatives board, and the same list for the other side is on alternatives to HelloWellness.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.